Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Chondroitin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    31 result(s) found for: Chondroitin. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2014-000906-36 Sponsor Protocol Number: GEB-IAL-2014-01 Start Date*: 2014-12-09
    Sponsor Name:Laboratorios Gebro Pharma S.A.
    Full Title: Randomized, parallel, multicenter, phase IV clinical trial to assess the efficacy of hyaluronic acid/chondroitin sulfate versus fosfomycin trometamol in recurrent urinary tract infection prevention.
    Medical condition: Recurrent urinary tract infections
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-005163-29 Sponsor Protocol Number: 05BFCH/Co04 Start Date*: 2006-03-09
    Sponsor Name:IBSA (Institut Biochimique SA)
    Full Title: “A multicentre, comparative, randomised, double-blind clinical trial on the equivalence of the efficacy and the safety of CHONDROSULF® 1200 mg, oral gel in sachet, once daily, versus CHONDROSULF® 4...
    Medical condition: Knee osteoarthritis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: Removed from public view
    EudraCT Number: 2009-016920-30 Sponsor Protocol Number: V1.1 Start Date*: 2013-10-23
    Sponsor Name:Medizinische Universitaet Wien, Universitaetsklinik für Radiologie und Nuklearmedizin
    Full Title: Non invasive imaging of human cartilage by scintigraphy using novel radiopharmaceutical 99mTcCS(chondroitin sulfate) to prove cartilage degeneration (osteoarthritis)in comparision with proteoglycan...
    Medical condition: Examination of the fundamental usefulness of 99mTcCS for scintigraphy.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2004-000534-36 Sponsor Protocol Number: PR 1903 Start Date*: 2004-09-13
    Sponsor Name:Laboratoires Expanscience
    Full Title: Efficacy and Safety of Piascledine 300 versus Chondroitin Sulfate in a 6 Months Treatment plus 2 Months Observation in Patients with Osteoarthritis of the Knee
    Medical condition: Osteoarthritis of the Knee
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SK (Completed) HU (Completed) CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-000444-26 Sponsor Protocol Number: TM-CS+SG/301 Start Date*: 2013-05-24
    Sponsor Name:Tedec-Meiji Farma, S.A.
    Full Title: Phase III clinical trial to evaluate the efficacy and safety of chondroitin sulphate and glucosamine sulphate in combination versus placebo in patients with osteoarthritis of the knee.
    Medical condition: Knee osteoarthritis.
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004859 10023476 Knee osteoarthritis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2015-005681-37 Sponsor Protocol Number: CL/BIO/15-005 Start Date*: 2016-04-18
    Sponsor Name:BIOIBERICA S.A.
    Full Title: Evaluation of the evolution of imaging markers of cartilage degradation in patients with knee osteoarthritis receiving DROGLICAN®: a Pilot Study
    Medical condition: Knee Osteoarthritis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2016-000998-20 Sponsor Protocol Number: DRO/IV-2016-ART-02 Start Date*: 2016-06-08
    Sponsor Name:BIOIBÉRICA S.A
    Full Title: Double-Blind, Randomised, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of the Combination of Chondroitin Sulphate and Glucosamine Hydrochloride in Patients with Hand Osteoa...
    Medical condition: symptomatic hand osteoarthritis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014516-35 Sponsor Protocol Number: L00023 GE 303 Start Date*: 2009-12-01
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: EFFICACY AND TOLERABILITY OF CHONDROITIN SULPHATE 1000MG, TWICE DAILY IN PATIENTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS
    Medical condition: Symptomatic knee osteoarthtitis
    Disease: Version SOC Term Classification Code Term Level
    12.0 10023476 Knee osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) LT (Completed) BE (Completed) EE (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2009-017468-18 Sponsor Protocol Number: CS/IV-RMF-01 Start Date*: 2010-07-02
    Sponsor Name:Bioibérica S.A.
    Full Title: Ensayo clínico aleatorizado, doble ciego, controlado con placebo para valorar el efecto de condroitín sulfato sobre el dolor en pacientes afectos de artrosis de rodilla mediante Resonancia Magnétic...
    Medical condition: Knee osteoarthritis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10023476 Knee osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-005398-22 Sponsor Protocol Number: ARACONDRO-001 Start Date*: 2012-10-11
    Sponsor Name:ARAFARMA GROUP, S.A.
    Full Title: A randomized, multicenter, double-blind, double dummy and parallel study to evaluate the efficacy of the combination of Chondroitin sulfate and Glucosamine hydrochloride in a single dose chewable t...
    Medical condition: Knee osteoarthritis with moderate to severe pain.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10023476 Knee osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-024010-61 Sponsor Protocol Number: DRO/IV-ART-01 Start Date*: 2011-11-09
    Sponsor Name:BIOIBERICA, S.A.
    Full Title: NON-INFERIORITY CLINICAL TRIAL ON THE EFFICACY AND SAFETY OF CHONDROITIN SULFATE AND GLUCOSAMINE HYDROCHLORIDE IN COMBINATION VERSUS CELECOXIB IN PATIENTS WITH KNEE OSTEOARTHRITIS
    Medical condition: KNEE OSTEOARTHRITIS
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10003416 Arthrosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed) ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-011173-32 Sponsor Protocol Number: RR09/8877 Start Date*: 2009-07-07
    Sponsor Name:University of Leeds
    Full Title: Treating painful hand osteoarthritis using low dose oral prednisolone- assessing short-term pain and imaging outcomes
    Medical condition: painful osteoarthritis of the hands
    Disease: Version SOC Term Classification Code Term Level
    9.1 10016686 Finger osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-005113-73 Sponsor Protocol Number: 20150114 Start Date*: 2016-07-01
    Sponsor Name:University Medical Center Groningen
    Full Title: Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation
    Medical condition: Type 2 diabetes with albuminuria
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021556-25 Sponsor Protocol Number: IBSA 01-2010 Start Date*: 2011-02-24
    Sponsor Name:IBSA
    Full Title: Phase III, randomized, open-label, multicenter evaluation of efficacy and tolerability `of Ialuril (sodium hyaluronate-chondroitin sulfate) vs. dimethyl sulfoxide (DMSO) in women with interstitial ...
    Medical condition: Interstitial Cystitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10018188 HLGT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-011039-11 Sponsor Protocol Number: RIZACONDRO Start Date*: 2009-12-01
    Sponsor Name:Fundació Clínic per a la Recerca Biomèdica
    Full Title: EFICACIA DEL TRATAMIENTO CON CONDROITIN SULFATO EN LA RIZARTROSIS. MEDICION CON TESTS SENSORIALES Y FUNCIONALES CUANTITATIVOS Y ANALISIS DE CONCORDANCIA CON ESCALAS SUBJETIVAS DE DOLOR.
    Medical condition: Rizartrosis
    Disease: Version SOC Term Classification Code Term Level
    9 10016686 Finger osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-005020-29 Sponsor Protocol Number: R475-OA-1611 Start Date*: 2018-04-10
    Sponsor Name:Regeneron Pharmaceuticals, Inc.
    Full Title: A Phase 3 Randomized, Double-blind, Multi-dose, Placebo and Naproxen-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip
    Medical condition: Pain due to osteoarthritis of the knee or hip
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004859 10023476 Knee osteoarthritis LLT
    21.1 100000004859 10020108 Hips osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Completed) LT (Completed) GB (GB - no longer in EU/EEA) DK (Completed) PL (Completed) HU (Completed) ES (Ongoing) RO (Completed)
    Trial results: View results
    EudraCT Number: 2005-000508-15 Sponsor Protocol Number: L00023 GE 404 Start Date*: 2005-10-06
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: Efficacy and safety assessment of 6 months (24 weeks) treatment with Structum® 500 mg capsule bid in hip osteoarthritis: multicenter randomised double blind parallel group and placebo controlled st...
    Medical condition: Patients with osteoarthritis of the hip
    Disease: Version SOC Term Classification Code Term Level
    7.0 10048793 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2015-003783-36 Sponsor Protocol Number: R475-PN-1523 Start Date*: 2016-05-19
    Sponsor Name:Regeneron Pharmaceuticals, Inc.
    Full Title: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip
    Medical condition: Pain due to osteoarthritis of the knee or hip
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004859 10023476 Knee osteoarthritis LLT
    21.1 100000004859 10020108 Hips osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Completed) DK (Completed) SE (Completed) DE (Completed) LT (Completed) GB (GB - no longer in EU/EEA) PL (Completed) ES (Completed) HU (Completed) RO (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2015-005691-26 Sponsor Protocol Number: 201501252 Start Date*: 2016-07-14
    Sponsor Name:University Medical Center Groningen
    Full Title: Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation
    Medical condition: Type 1 diabetes with albuminuria
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing) DK (Completed)
    Trial results: View results
    EudraCT Number: 2017-001702-15 Sponsor Protocol Number: R475-OA-1688 Start Date*: 2018-03-05
    Sponsor Name:Regeneron Pharmaceuticals, Inc.
    Full Title: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo And NSAID-Controlled Study To Evaluate The Efficacy And Safety Of Fasinumab In Patients With Pain Due To Osteoarthritis Of The Knee Or Hip
    Medical condition: Pain due to osteoarthritis of the knee or hip
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004859 10023476 Knee osteoarthritis LLT
    20.0 100000004859 10020108 Hips osteoarthritis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended) DE (Completed) EE (Completed) GB (GB - no longer in EU/EEA) RO (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 25 08:30:15 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA